Literature DB >> 10089786

Incidence of inflammatory bowel disease in the 02 health area of Castellon (1992-1996).

R Monferrer Guardiola1, J A Martín Jiménez, R G Pedraza Sanz, I Moreno Sánchez, E Soler Bahilo, J Hinojosa del Val.   

Abstract

OBJECTIVES: To evaluate the incidence and distribution of inflammatory bowel disease (IBD) in the 02 health area of the province of Castellon.
METHODS: Retrospective study of 133 cases of inflammatory bowel disease (in 72 males and 61 females aged 13 to 86 years), diagnosed during the period from 1992 to 1996 in an eminently rural area with a population of 349,318 inhabitants.
RESULTS: The incidence of IBD was 9.5 cases/100,000 inhabitants/year (6.8, 1.9 and 0.8 cases/100,000 inhabitants/year for ulcerative colitis, Crohn's disease and indeterminate colitis respectively). Incidence was similar in males and females (sex ratio 1.18:1), and average age was 40.9 years (42.6, 35.8 and 38.6 for ulcerative colitis, Crohn's disease and indeterminate colitis respectively). The predominant clinical forms were rectosigmoiditis in ulcerative colitis, granulomatous colitis and terminal colitis in Crohn's disease and proctosigmoiditis in indeterminate colitis.
CONCLUSION: The incidence and the forms of presentation of IBD in the 02 health area of the province of Castellon are similar to those reported in the rest of Spain, mainly in the urban population.

Entities:  

Mesh:

Year:  1999        PMID: 10089786

Source DB:  PubMed          Journal:  Rev Esp Enferm Dig        ISSN: 1130-0108            Impact factor:   2.086


  2 in total

Review 1.  Is There a Link Between H. Pylori and the Epidemiology of Crohn's Disease?

Authors:  Ayesha Shah; Nicholas J Talley; Marjorie Walker; Natasha Koloski; Mark Morrison; Daniel Burger; Jane M Andrews; Michael McGuckin; Mike Jones; Gerald Holtmann
Journal:  Dig Dis Sci       Date:  2017-03-09       Impact factor: 3.199

2.  EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.

Authors:  María Chaparro; Manuel Barreiro-de Acosta; José Manuel Benítez; José Luis Cabriada; María José Casanova; Daniel Ceballos; María Esteve; Hipólito Fernández; Daniel Ginard; Fernando Gomollón; Rufo Lorente; Pilar Nos; Sabino Riestra; Montserrat Rivero; Pilar Robledo; Cristina Rodríguez; Beatriz Sicilia; Emilio Torrella; Ana Garre; Esther García-Esquinas; Fernando Rodríguez-Artalejo; Javier P Gisbert
Journal:  Therap Adv Gastroenterol       Date:  2019-05-21       Impact factor: 4.409

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.